Key Record Dates Identifier: NCT02513394
Brief Title: PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer (PALLAS)

First Submitted : July 29, 2015
First Submitted that Met QC Criteria : July 30, 2015
First Posted : July 31, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : August 31, 2018
Last Update Posted : September 3, 2018 (Estimate)